Study on the mechanism of the annexin II-mediated co-assembly of t-PA and plasminogen

J Huazhong Univ Sci Technolog Med Sci. 2002;22(1):21-3, 76. doi: 10.1007/BF02904779.

Abstract

In order to further investigate the effect of annexin II (Ann-II) on tissue plasminogen activator (t-PA)-dependent plasminogen (PLG) activation and its interactive mechanism, recombinant native Ann-II bound t-PA, PLG and plasmin with high affinity was examined. The flow cytometric assay showed that the ann-II expression rate was higher in the human umbilical vein endothelial cell (HUVEC) (87.65%) than in the HL-60 cells as controls (35.79%). Two irrelevant proteins, bovine serum albumin (BSA) and equine IgG (EIG) had no effect on the production of plasmin. Ann-II-mediated enhancement of t-PA-dependent PLG activation was inhibited by epsilon-aminocaproic acid or by pretreatment of Ann-II with carboxypeptidase B with the inhibitive rate being 77.8% and 77.0%, respectively. It was revealed that the effect of Ann-II on PLG activation was specific for t-PA. Urokinase didn't bind to Ann-II, demonstrating the role of receptor-related lysine residues on activation of PLG, showing that the Ann-II-PLG interaction was dependent upon carboxyl-terminal lysine residues. These findings suggest that annexin II-mediated co-assembly of t-PA and PLG may promote plasmin generation and play a key role in modulating fibrinolysis on the endothelial surface.

MeSH terms

  • Annexin A2 / pharmacology*
  • Cells, Cultured
  • Endothelium, Vascular / cytology
  • Endothelium, Vascular / metabolism*
  • Fibrinolysis
  • Humans
  • Plasminogen / metabolism*
  • Recombinant Proteins / pharmacology
  • Tissue Plasminogen Activator / metabolism*
  • Umbilical Veins / cytology

Substances

  • Annexin A2
  • Recombinant Proteins
  • Plasminogen
  • Tissue Plasminogen Activator